Abeona Therapeutics

ABEO55

$5.86arrow_drop_down1.51%-$0.08

ABEO55

$5.86

arrow_drop_down1.51%-$0.08

Performance History

Key Stats
Open	$5.95
Prev. Close	$5.95
EPS	-1.77
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	5.79	5.97
52 Week Range	3.05	9.01

Ratios







EPS	-1.77

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Abeona Therapeutics (ABEO)

Abeona Therapeutics Inc (ABEO) is a biopharmaceutical company focused on developing and delivering gene therapies for severe and life-threatening rare genetic diseases. The company's pipeline includes both preclinical and clinical-stage programs targeting a range of diseases, including Sanfilippo syndrome, Batten disease, and Recessive Dystrophic Epidermolysis Bullosa (RDEB). With a mission to transform the lives of patients with genetic diseases, Abeona Therapeutics is committed to developing innovative therapies that address significant unmet medical needs.

Abeona Therapeutics' stock price history has shown both volatility and growth. Over the past year, ABEO has experienced a 52-week range of $1.50 to $8.41 per share. The day range for ABEO stock varies based on market conditions and investor activity. Trading volume for Abeona Therapeutics tends to fluctuate, reflecting interest and activity in the stock. Investors should closely monitor market trends and news related to the biopharmaceutical industry for insights into ABEO's performance.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Headquarters: New York
Employees: 57
Exchange: NASDAQ

Keep an eye on Abeona Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Abeona Therapeutics 's (ABEO) price per share?

The current price per share for Abeona Therapeutics (ABEO) is $5.86. The stock has seen a price change of -$0.09 recently, indicating a -1.51% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Abeona Therapeutics (ABEO)?

For Abeona Therapeutics (ABEO), the 52-week high is $9.01, which is 53.75% from the current price. The 52-week low is $3.05, the current price is 92.13% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Abeona Therapeutics (ABEO) a growth stock?

Abeona Therapeutics (ABEO) has shown an average price growth of -6.65% over the past three years. It has received a score of 31 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Abeona Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Abeona Therapeutics (ABEO) stock price performance year to date (YTD)?

As of the latest data, Abeona Therapeutics (ABEO) has a year-to-date price change of 5.97%. Over the past month, the stock has experienced a price change of -10.12%. Over the last three months, the change has been 17.2%. Over the past six months, the figure is 27.39%. Looking at a longer horizon, the five-year price change stands at -89.49%.

help

Is Abeona Therapeutics (ABEO) a profitable company?

Abeona Therapeutics (ABEO) has a net income of -$54.19M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 69.57% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $3.5M, although specific revenue growth data is currently not available. The gross profit is $2.44M. Operating income is noted at -$47.14M. Furthermore, the EBITDA is -$54.75M.

help

What is the market capitalization of Abeona Therapeutics (ABEO)?

Abeona Therapeutics (ABEO) has a market capitalization of $253.82M. The average daily trading volume is 5.86, indicating the stock's liquidity and investor engagement.